ALS Shares Break Through Recent Range As Markets Work Through FY26 Print

ALS Ltd shares (ASX:ALQ) rallied 5.93% today to break above A$23 for the first time since March, as markets digested the full implications of the testing and inspection group’s record FY26 result and shrugged off an initial post-earnings pullback.

The ALS share price sits above the A$23 level today at A$23.13 at close, a reversal of sorts after pulling back 1.67% yesterday following its latest earnings release. That initial dip, a classic sell the news response has given way to renewed buying as analysts and portfolio managers focused on the quality and sustainability of the company’s margin expansion, with Bell Potter reaffirming its buy rating today, albeit with a price target that was trimmed from A$28 to A$26. The stock has now climbed approximately 30% over the past twelve months, rewarding shareholders who stayed through a volatile exploration cycle and a capital-raising event in mid-2025.

Record Financials

ALS reported revenue of A$3.32 billion for FY26, up 10.7% year-on-year, while underlying earnings before interest and tax climbed 19.3% to A$599 million. The EBIT margin expanded 129 basis points to 18.0%, a sharp reversal from the margin compression experienced in FY25. Underlying net profit after tax reached a record A$381.2 million, up 25.8%, demonstrating powerful operating leverage as the company’s capacity investments and automation initiatives began to flow through to the bottom line.

The Commodities division—particularly Minerals and Geochemistry—delivered the standout performance, with organic revenue growth of approximately 20% and margins exceeding 30% for the fifth consecutive year. Within that segment, Geochemistry EBIT margins reached roughly 29.5%, up 167 basis points, as sample volumes from both major miners and junior explorers remained robust through the second half. Management highlighted sustained strength in critical minerals and energy-transition-linked commodities as a key driver, with junior miners’ sample volumes growing at least as fast as those from established producers.

Life Sciences, the company’s other major division, posted more modest gains. Management described the performance as “mixed growth,” with improvements in food testing and certain environmental markets offset by margin pressure in industrial sub-sectors such as Oil & Lubricants and Coal testing.

The final dividend was lifted to 23.1 cents per share, partially franked, representing an approximate 17% increase over the FY25 final payout of 19.7 cents. The dividend growth underscores management’s confidence in cash generation and earnings durability, even as the company continues to invest heavily in laboratory upgrades and digital infrastructure.

What Next For ALS

Looking ahead, the key question is whether ALS can sustain elevated margins and volume growth as the exploration cycle matures. Management’s commentary points to continued strength in mineral exploration, particularly in critical minerals tied to the energy transition, as a reason to expect a longer-than-typical upcycle. The company’s investments in automation and digital tools are designed to defend margins when the cycle eventually cools, differentiating ALS from smaller or less capitalised laboratory peers.

Yet the cyclical risks remain real. The sharp step-up in earnings is concentrated in Commodities, especially Geochemistry, which is tightly linked to exploration spending. If commodity prices soften or capital markets for junior miners tighten, revenue and margins could normalise quickly.

ALS share price breaking out of the recent range above A$23 reflects a market that has decided the company’s record FY26 performance and structural margin gains justify a higher valuation range, with a reaffirmed bullish rating helping sentiment further. With shares up 5.93%, and one of those leading the ASX 200 on the day, bulls will be looking for more of the same in the sessions ahead.